Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - SEELOS THERAPEUTICS, INC. | apri123115ex21.htm |
| EX-23.2 - EXHIBIT 23.2 PWC - SEELOS THERAPEUTICS, INC. | apri123115ex232pwc.htm |
| EX-32.1 - EXHIBIT 32.1 - SEELOS THERAPEUTICS, INC. | apri123115ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - SEELOS THERAPEUTICS, INC. | apri123115ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - SEELOS THERAPEUTICS, INC. | apri123115ex311.htm |
| EX-23.1 - EXHIBIT 23.1 BDO - SEELOS THERAPEUTICS, INC. | apri123115ex231bdo.htm |
| 10-K - APRI 2015 10-K - SEELOS THERAPEUTICS, INC. | apri12311510k.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF ACCOUNTING OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Catherine Bovenizer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Apricus Biosciences, Inc. on Form 10-K for the year ended December 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Apricus Biosciences, Inc.
Date: March 9, 2016 | By: | /S/ CATHERINE BOVENIZER |
Name: | Catherine Bovenizer | |
Title: | Chief Accounting Officer | |